TrialSpark

Built a technology-driven model for running trials with an emphasis on speed and data infrastructure. Note that its corporate focus has moved substantially toward in-house drug development, so confirm current service availability before shortlisting.

Study-scoped; confirm current commercial model directly.

Whatever the structure, convert it to cost per randomized patient before you compare proposals. Cost per referral is the number vendors prefer to quote and the number that tells you least.

• Strong technology and data engineering foundations

• Verify that trial-services work is still actively sold before spending RFP time
• Strategic pivots make multi-year commitments riskier

Worth it when: Sponsors specifically evaluating technology-led execution models.

Not worth it when: Anyone who needs certainty of vendor continuity across a long program.

• Lindus HealthAll-in-one CRO bundling recruitment, sites, and eClinical with fixed pricing.
• CuravitVirtual CRO focused on digital therapeutics and decentralized designs.
• Science 37Decentralized trial operating system with telemedicine investigators and nurses.

• Lindus Health vs TrialSpark — Bundled fixed-price CRO versus technology-led execution.

Ask for the referral-to-randomization ratio on three studies resembling yours, in the same indication and the same countries. If a vendor will not give it, that is the answer. If your enrollment forecast itself is the shaky part, our sister publication Rock Enroll covers forecasting and rescue in depth.